Last checked at Today 11:23
AstraZeneca aims for $80 bln in total revenue by 2030
Sees $80 bln in 2030 revenue by 2030
*Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News2
GSK Share
Chat
GSK Share
Trades8,577
GSK
Live RNS1
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,756.00
Bid:
1,753.00
Ask:
1,754.00
Change:
-19.00 (-1.07%)
Spread:
1.00 (0.057%)
Open:
1,770.00
High:
1,770.00
Low:
1,740.00
Prev. Close:
1,775.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Liberum downgrades Glaxo to 'sell' on uncertain outlook
Wed, 30th Jul 2014 11:53
Liberum Capital has lowered its recommendation for pharmaceutical group Glaxosmithkline (GSK) from 'hold' to 'sell', saying it sees an uncertain outlook for the business.The broker has slashed its target price for the stock from 1,500p to 1,350p."Our analysis shows the immense pressure the business is under is likely to lead to underinvestment in core areas," Liberum explained.The analysts said that while GSK's recent multi billion-pound asset swap with Novartis may look like the company has diversified away from pharma to more 'sustainable' consumer and vaccine businesses, pharma will still account for 73% of earnings in 2016."Despite the smoke and mirrors - GSK is still a pharma business with no pipeline or innovation," Liberum said.The broker said it has cut its forecasts "dramatically" and now estimates earnings per share of just 91p this year, down 16% from 2013."We show that the dividend is safe for the foreseeable future but we believe it could be at risk if: 1) things get worse operationally 2) a change in 'strategy' leads to more investment in R&D and selling, general and admin expenses 3) M&A leads to a cut in the div." Despite the gloomy comments, the stock was up 0.5% at 1,425.5p by 11:40.BC
More News
Today 08:49
GSK's depemokimab asthma treatment meets endpoints in latest trials
(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.
Read moreToday 07:21
GSK reports promising results from asthma treatment trials
(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.
Read more20 May 2024 16:11
IN BRIEF: GSK executive buys GBP20,026 worth shares
GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.
Read more17 May 2024 17:38
London's FTSE nudges lower for week after record run
Haleon falls after GSK offloads remaining stake
*Read more17 May 2024 15:52
London close: Stocks recoup some earlier losses
(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.
Read more17 May 2024 11:52
LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady
(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.
Read more17 May 2024 09:03
TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion
(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.
Read more17 May 2024 08:56
LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends
(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.
Read more17 May 2024 08:39
GSK raises $1.5 bln from sale of remaining Haleon stake
May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.
Read more17 May 2024 07:42
LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake
(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.
Read more17 May 2024 07:29
GSK raises £1.25bn from sale of remaining Haleon stake
(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.
Read more16 May 2024 17:33
FTSE 100 ends lower on disappointing corporate updates, BT Group soars
BT Group up after CEO aims for more than double free cash flow
*Read more16 May 2024 17:13
TOP NEWS: GSK to sell remaining holding in spin-off Haleon
(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.
Read more16 May 2024 17:02
GSK to sell entire 4.2% remaining stake in Haleon
(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.
Read more